BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

296 related articles for article (PubMed ID: 19358830)

  • 1. Identification of a common microdeletion cluster in 7q21.3 subband among patients with myeloid leukemia and myelodysplastic syndrome.
    Asou H; Matsui H; Ozaki Y; Nagamachi A; Nakamura M; Aki D; Inaba T
    Biochem Biophys Res Commun; 2009 May; 383(2):245-51. PubMed ID: 19358830
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Haploinsufficiency of SAMD9L, an endosome fusion facilitator, causes myeloid malignancies in mice mimicking human diseases with monosomy 7.
    Nagamachi A; Matsui H; Asou H; Ozaki Y; Aki D; Kanai A; Takubo K; Suda T; Nakamura T; Wolff L; Honda H; Inaba T
    Cancer Cell; 2013 Sep; 24(3):305-17. PubMed ID: 24029230
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Submicroscopic deletions at 7q region are associated with recurrent chromosome abnormalities in acute leukemia.
    Basiricò R; Pirrotta R; Fabbiano F; Mirto S; Cascio L; Pagano M; Cammarata G; Magrin S; Santoro A
    Haematologica; 2003 Apr; 88(4):429-37. PubMed ID: 12681970
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clonal heterogeneity in childhood myelodysplastic syndromes--challenge for the detection of chromosomal imbalances by array-CGH.
    Praulich I; Tauscher M; Göhring G; Glaser S; Hofmann W; Feurstein S; Flotho C; Lichter P; Niemeyer CM; Schlegelberger B; Steinemann D
    Genes Chromosomes Cancer; 2010 Oct; 49(10):885-900. PubMed ID: 20589934
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chromosome 5q deletion and epigenetic suppression of the gene encoding alpha-catenin (CTNNA1) in myeloid cell transformation.
    Liu TX; Becker MW; Jelinek J; Wu WS; Deng M; Mikhalkevich N; Hsu K; Bloomfield CD; Stone RM; DeAngelo DJ; Galinsky IA; Issa JP; Clarke MF; Look AT
    Nat Med; 2007 Jan; 13(1):78-83. PubMed ID: 17159988
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fluorescence in situ hybridization analysis of 110 hematopoietic disorders with chromosome 5 abnormalities: do de novo and therapy-related myelodysplastic syndrome-acute myeloid leukemia actually differ?
    Lessard M; Hélias C; Struski S; Perrusson N; Uettwiller F; Mozziconacci MJ; Lafage-Pochitaloff M; Dastugue N; Terré C; Brizard F; Cornillet-Lefebvre P; Mugneret F; Barin C; Herry A; Luquet I; Desangles F; Michaux L; Verellen-Dumoulin C; Perrot C; Van den Akker J; Lespinasse J; Eclache V; Berger R;
    Cancer Genet Cytogenet; 2007 Jul; 176(1):1-21. PubMed ID: 17574959
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structural aberrations of chromosome 7 revealed by a combination of molecular cytogenetic techniques in myeloid malignancies.
    Brezinová J; Zemanová Z; Ransdorfová S; Pavlistová L; Babická L; Housková L; Melichercíková J; Sisková M; Cermák J; Michalová K
    Cancer Genet Cytogenet; 2007 Feb; 173(1):10-6. PubMed ID: 17284364
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The enigma of monosomy 7.
    Inaba T; Honda H; Matsui H
    Blood; 2018 Jun; 131(26):2891-2898. PubMed ID: 29615405
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Myelodysplastic syndrome associated with monosomy 7 in childhood: a retrospective study.
    Aktas D; Tuncbilek E
    Cancer Genet Cytogenet; 2006 Nov; 171(1):72-5. PubMed ID: 17074595
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Redefining monosomy 5 by molecular cytogenetics in 23 patients with MDS/AML.
    Herry A; Douet-Guilbert N; Morel F; Le Bris MJ; De Braekeleer M
    Eur J Haematol; 2007 Jun; 78(6):457-67. PubMed ID: 17391336
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Molecular cytogenetic analysis of -7/7q- abnormalities in patients with myeloid malignancies].
    Xiao Y; Liu SH; Liu XP; Qin S; Bo LJ; Li CW; Dai Y; Wang JS
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2003 Dec; 20(6):471-6. PubMed ID: 14669212
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chromosome 20 deletions in myeloid malignancies: reduction of the common deleted region, generation of a PAC/BAC contig and identification of candidate genes. UK Cancer Cytogenetics Group (UKCCG).
    Bench AJ; Nacheva EP; Hood TL; Holden JL; French L; Swanton S; Champion KM; Li J; Whittaker P; Stavrides G; Hunt AR; Huntly BJ; Campbell LJ; Bentley DR; Deloukas P; Green AR
    Oncogene; 2000 Aug; 19(34):3902-13. PubMed ID: 10952764
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Abnormalities of chromosome 17 in myeloid malignancies with complex chromosomal abnormalities].
    Zhu Y; Xu W; Liu Q; Pan J; Qiu H; Wang R; Qiao C; Jiang Y; Zhang S; Fan L; Zhang J; Shen Y; Xue Y; Li J
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2008 Oct; 25(5):579-82. PubMed ID: 18841577
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Deletions of chromosome arms 7p and 7q in adult acute myeloid leukemia: a marker chromosome confirmed by array comparative genomic hybridization.
    Woo KS; Kim KE; Kim KH; Kim SH; Park JI; Shaffer LG; Han JY
    Cancer Genet Cytogenet; 2009 Oct; 194(2):71-4. PubMed ID: 19781438
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of chromosome 5 aberrations in complex karyotypes of patients with myeloid disorders reveals their contribution to dicentric and tricentric chromosomes, resulting in the loss of critical 5q regions.
    Herry A; Douet-Guilbert N; Morel F; Le Bris MJ; Morice P; Abgrall JF; Berthou C; De Braekeleer M
    Cancer Genet Cytogenet; 2007 Jun; 175(2):125-31. PubMed ID: 17556068
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Myelodysplastic syndrome, juvenile myelomonocytic leukemia, and acute myeloid leukemia associated with complete or partial monosomy 7. European Working Group on MDS in Childhood (EWOG-MDS).
    Hasle H; Aricò M; Basso G; Biondi A; Cantù Rajnoldi A; Creutzig U; Fenu S; Fonatsch C; Haas OA; Harbott J; Kardos G; Kerndrup G; Mann G; Niemeyer CM; Ptoszkova H; Ritter J; Slater R; Starý J; Stollmann-Gibbels B; Testi AM; van Wering ER; Zimmermann M
    Leukemia; 1999 Mar; 13(3):376-85. PubMed ID: 10086728
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Heterogeneity of structural abnormalities in the 7q31.3 approximately q34 region in myeloid malignancies.
    González MB; Gutiérrez NC; García JL; Schoenmakers EF; Solé F; Calasanz MJ; San Miguel JF; Hernández JM
    Cancer Genet Cytogenet; 2004 Apr; 150(2):136-43. PubMed ID: 15066321
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nuclear phospholipase C beta1, regulation of the cell cycle and progression of acute myeloid leukemia.
    Cocco L; Manzoli L; Palka G; Martelli AM
    Adv Enzyme Regul; 2005; 45():126-35. PubMed ID: 16024064
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular cytogenetic delineation of deletions and translocations involving chromosome band 7q22 in myeloid leukemias.
    Fischer K; Fröhling S; Scherer SW; McAllister Brown J; Scholl C; Stilgenbauer S; Tsui LC; Lichter P; Döhner H
    Blood; 1997 Mar; 89(6):2036-41. PubMed ID: 9058725
    [TBL] [Abstract][Full Text] [Related]  

  • 20. AML/MDS with 11q/MLL amplification show characteristic gene expression signature and interplay of DNA copy number changes.
    Zatkova A; Merk S; Wendehack M; Bilban M; Muzik EM; Muradyan A; Haferlach C; Haferlach T; Wimmer K; Fonatsch C; Ullmann R
    Genes Chromosomes Cancer; 2009 Jun; 48(6):510-20. PubMed ID: 19306356
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.